IPHA

Innate Pharma

11 hedge funds and large institutions have $483K invested in Innate Pharma in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$179K
2 +$157K
3 +$54.9K
4
Millennium Management
Millennium Management
New York
+$39.2K
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$9.14K

Top Sellers

1 -$39.1K
2 -$13.8K
3 -$7.43K
4
GI
GAMMA Investing
California
-$2.33K
5
Barclays
Barclays
United Kingdom
-$591